The global malaria
diagnostics market is expected to register a significant growth of 4.6 % CAGR
during the forecast period (2018–2023)
Malaria is a serious
life-threatening disease caused by a parasite, transmitted by the bite of
infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium
parasite. When the infected mosquito bites you, the parasite is released into
your bloodstream. Once the human body becomes the host for the parasite it
travels to the liver and matures. After some days, the mature parasite enters
the bloodstream and starts to infect red blood cells (RBC). Humans suffering
from malaria frequently experience fever, headache, weakness, vomiting
The
improvements in technological advancements related to diagnostic tools with the
growing demand for treatment in malaria-endemic countries is driving this
market. Major factors driving the growth of the market are raising funds from
the government, an increase in association between the industry and research
centers. In the current years, there has been a renewed interest and commitment
by the World Health Organization (WHO) to eradicate malaria in around 35
countries by 2030. World Health Organization (WHO) also estimated that by 2016,
there would be 216 million clinical episodes and 445,000 deaths only due to
malaria. The malaria diagnostic tests play a major role in recognizing the
malarial cases and thus boosting the growth of malaria diagnosis market.
However,
the dearth of appropriate monitoring standards at the country levels
particularly in developing markets hinders the growth of the market. The weak
regulatory framework and lack of awareness across the emerging nations is a
prime concern for the manufacturers and healthcare providers. The absence of
strong import export guidelines can lead to the use of substandard products
that can lead to additional complications for patients. Besides, the long
registration procedures, the market entry parameters must be assessed carefully
for investment considerations.
Segmentation
The
global malaria diagnostics market has been segmented on the basis of technology
and end-user.
On the
basis of technology, the market has been classified as rapid diagnostic tests,
microscopy, and molecular diagnostic tests. The molecular diagnostics tests are
segmented into polymerase chain reaction (PCR) and real-time polymerase chain
reaction (RT-PCR).
On the
basis of end-users, the market has been classified as hospitals, clinics,
community healthcare, and others.
On the
basis of region, the market is segmented into the Americas, Europe,
Asia-Pacific, and the Middle East and Africa. The Americas has been further
segmented into North America and South America, with the North American market
divided into the US and Canada.
The
European malaria diagnostics market has been segmented into Western Europe and
Eastern Europe. Western Europe has further been classified as Germany, France,
the UK, Italy, Spain, and the rest of Western Europe.
The
malaria diagnostics market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. The malaria
diagnostics market in the Middle East and Africa has been segmented into the
Middle East and Africa.
Regional
Market Summary
In the
malaria diagnostics market, North America is anticipated to account for the
largest market share due to the early adoption of advanced medical
technologies, the rise in awareness, the rise in growth of the healthcare sector,
and due to favorable compensation setting for many surgical procedures. In
2016, global governments of malaria-endemic countries have invested USD 2.7
billion in malaria control and elimination efforts. The US was the largest
contributor by providing USD 1 billion for the eradication of malaria.
The
European market is expected to hold the least share due to the growing number
of malaria-free countries in the region.
The
market share in Asia-Pacific is also projected to experience growth in the near
future due to access to optimal treatment facilities and growing demand for
advanced technology, better adoption rate, increase in disposable income, and
rising medical tourism. The Asia-Pacific remains to be the second largest
burden of malaria globally with 22 malaria-endemic countries accounting for
roughly 28 million cases and 45,000 deaths every year. The WHO figures say that
in the Asia-Pacific region, Myanmar, Pakistan, India, and Indonesia carry the
highest malaria burden accounting for 89% of all malaria cases in the region.
The
market in the Middle East and Africa is expected to account for the smallest
share of the global malaria diagnostics market due to an underdeveloped
healthcare sector, lack of technical knowledge, and poor medical facilities.
Sub-Saharan Africa remains to bring an excessively high share of the global
malaria burden on the Middle Eastern and African market. the region was home to
90% of malaria incidences and 92% of malaria deaths in 2015
Key
Players
Some of
the key players in the global malaria diagnostics market are Access Bio. Inc.,
Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH,
bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems
GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.
Browse Complete 100 Pages Premium Research Report
Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/malaria-diagnostics-market-6432
Detailed
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued
About US:
Market Research Future (MRFR), enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment